Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04686799
PHASE1

Doxycycline for Elbow Tendinopathy

Sponsor: Hospital for Special Surgery, New York

View on ClinicalTrials.gov

Summary

To evaluate the feasibility of subantimicrobial -dose (SD) doxycycline to improve outcomes of nonsurgical management of elbow tendinopathy via matrix metalloproteinase (MMP) inhibition as well as evaluate if participants will be compliant to with prescribed medication and exercise treatment. Our working hypothesis is that patients with elbow tendinopathy will be receptive to treatment with SD-doxycycline and compliant with the prescribed treatment.

Official title: Evaluating the Feasibility of Subantimicrobial-dose Doxycycline for Elbow Tendinopathy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2020-12-03

Completion Date

2026-01

Last Updated

2025-12-16

Healthy Volunteers

No

Interventions

DRUG

Doxycycline Hyclate 20 MG

Subjects will receive doxycycline 20 mg BID

Locations (1)

Hospital for Special Surgery

New York, New York, United States